Medical Marijuana Market worth over $55 billion by 2024:

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
51
Medical Marijuana Market worth over $55 billion by 2024: Global Market Insights, Inc.

Sellbyville, Delaware, Aug. 22, 2018 (GLOBE NEWSWIRE) --

Global Medical Marijuana Market outlook is projected to surpass USD 55 billion by 2024, says a new Global Market Insights, Inc. report featuring key industry trends across the application, route of administration, distribution channel, and regional landscape.   

The extensive demand for marijuana in the treatment of chronic pain due to cancer, arthritis, HIV/AIDS, and cancer will foster the global medical marijuana market growth. The rising inclination toward marijuana as opposed to opioid narcotics will also influence the industry trends.  

According to the report, medical marijuana market size from dispensaries is foreseen to exhibit a double-digit CAGR of 36.2% over 2018-2024. Powered by the increasing number of dispensaries set up in myriad regions and growth in the legal sale of medical marijuana have optimistically influenced and proliferated the segment growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2836

In terms of the regional landscape, Canada medical marijuana industry is projected to witness 32% CAGR over 2018-2024. The country has completely legalized the sale, production, & consumption of medical marijuana and is thus witnessing robust product sales. Presence of prominent marijuana companies in the region is also expected to drive the regional share.

The key players profiled in the report are GW Pharmaceuticals, Aphria, Aurora Cannabis Inc., Canopy Growth Corporation, Medical Marijuana, Inc., Supreme Cannabis Company Inc., MedReleaf, CanniMed Therapeutics Inc., Lexaria Corporation, Tilray, United Cannabis Corporation, Emerald Health Therapeutics, Cannabis Sativa, Inc., Cronos Group, GBSciences, Inc., The Hydropothecary Corporation, Corbus Pharmaceuticals, Namaste Technologies, and Insys Therapeutics, Inc. The companies have been profiled in terms of their strategic outlook, product portfolio, and SWOT assessment.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2836

Scope of the Medical Marijuana Market report:

  • Application landscape: Pain Management (Cancer Pain, Neuropathic Pain), Muscle Spasms, Nausea, Anorexia, Seizures, Others
  • Route of administration landscape: Inhalation, Oral, Topical
  • Distribution channel landscape: Dispensaries, Online
  • Regional landscape: Canada, U.S., UK, Germany, Czech Republic, France, Italy, The Netherlands, Chile, Peru, Argentina, Colombia, Israel, Australia

Browse key industry insights spread across 150 pages with 161 market data tables & 9 figures & charts from the report, “Medical Marijuana Market” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/...ana-market

Partial Table of Contents (ToC) of the report:

Chapter 2.  Executive Summary

2.1.  Medical marijuana industry 360 0  synopsis, 2013 - 2024

2.1.1.  Business trends

2.1.2.  Application trends

2.1.3.  Route of administration trends

2.1.4.  Distribution channel trends

2.1.5.  Regional trends

Chapter 3.  Medical Marijuana Industry Insights

3.1.  Industry segmentation

3.2.  Industry landscape, 2013 – 2024

3.3.  Industry impact forces

3.3.1.  Growth drivers

3.3.1.1. Increasing application of marijuana for a myriad of medical conditions and symptoms

3.3.1.2. Growing demand for medical marijuana legalization in several countries

3.3.1.3. Rising number of R&D and clinical trial activities

3.3.2.  Industry pitfalls & challenges

3.3.2.1. Few side effects might hinder the market growth

3.3.2.2. Difficulty in medical marijuana business banking

3.4.  Growth potential analysis

3.4.1.  By application

3.4.2.  By route of administration

3.4.3.  By distribution channel

3.5.  Porter’s analysis

3.6.  Competitive landscape, 2017

3.6.1.  Business overview

3.6.2.  Revenue analysis

3.6.3.  Product landscape

3.6.4.  Strategy dashboard

3.7.  PESTEL analysis

3.8.  Value chain analysis        

3.9.  Legal Requirement for Distribution of Medical Marijuana        

3.10. Regulatory Landscape, by Country        

3.10.1. US    

3.10.2. Canada       

3.10.3. The Netherlands     

3.10.4. Israel

Chapter 4.  Medical Marijuana Market, By Application

4.1. Global medical marijuana market share, by application, 2017 & 2024

4.2. Pain Management

4.2.1.  Market estimates and forecast, by region, 2013 – 2024

4.2.2.  Neuropathic Pain

4.2.2.1.    Market estimates and forecast, by region, 2013 – 2024

4.2.3.  Cancer Pain

4.2.3.1.    Market estimates and forecast, by region, 2013 – 2024

4.2.4.  Others

4.2.4.1.    Market estimates and forecast, by region, 2013 – 2024

4.3. Muscle Spasms

4.3.1.  Market estimates and forecast, by region, 2013 – 2024

4.4. Nausea

4.4.1.  Market estimates and forecast, by region, 2013 - 2024

4.5. Anorexia

4.5.1.  Market estimates and forecast, by region, 2013 - 2024

4.6. Seizures

4.6.1.  Market estimates and forecast, by region, 2013 - 2024

4.7. Others

4.7.1.  Market estimates and forecast, by region, 2013 – 2024

Browse Full ToC @   https://www.gminsights.com/toc/detail/medical...ana-market

Browse Related Reports:

Fibromyalgia Treatment Market Size 2018-2024

Fibromyalgia Treatment Market revenue is projected to experience significant growth from 2018 to 2024. Rising burden of chronic pain due to rheumatic conditions across the globe will drive fibromyalgia treatment market growth over the forecast timeline. Reoccurrence of rheumatic arthritis leads to fibromyalgia syndrome.

https://www.gminsights.com/industry-analysis/...ent-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us: Arun Hegde Corporate Sales, USA Global Market Insights, Inc. Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: sales@gminsights.com Web: https://www.gminsights.com Blog: http://www.cmferesearch.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Robert Half's Parent Support Earns Fortune Recognition

Updated Category News Views 92

A workplace award rarely moves a staffing stock by itself, and it shouldn’t. Still, Fortune naming Robert Half among its Best Workplaces for Parents for 2026 is more than decorative corporate wallpaper. In the talent business, the company’s own ability to recruit, retain and support people is part of the product. Clients hire Robert Half because they need skilled...

Continue Reading
NextPlat’s 150-Patient Test Has a Long Road Ahead

Updated Category News Views 114

A strip of pills can look mundane, yet it is where this entire NextPlat pitch either earns its keep or falls apart. PharmcoRx has signed a partner pharmacy agreement with MedSure Systems for a 150-patient Medicare medication-adherence pilot in South Florida. That is a small starting line, no two ways around it. Still, the mechanics are more interesting than another vague...

Continue Reading
Holland America Puts 2028 Alaska Demand on Display

Updated Category News Views 156

Alaska’s interior is where a cruise brochure either earns its keep or gets exposed. Holland America Line is opening bookings for 2028 Alaska Cruisetours nearly two years ahead, tying a coast-and-land product to the reimagined Oosterdam’s Alaska debut. That is not merely another itinerary release. It is a fairly deliberate attempt to sell a bigger, longer and...

Continue Reading
Wenge AI Removes a Small Friction Point for ScienceOra

Updated Category News Views 31

Scientific software rarely loses users because the underlying model is too clever; it loses them because getting through the front door is a nuisance. Wenge AI has addressed that unglamorous problem by adding Google and Apple sign-in options to the international version of ScienceOra, its AI-powered research and decision-support platform. This is not the sort of...

Continue Reading
JDEnergy's RE+ Push Meets a Grid Hungry for Storage

Updated Category News Views 90

Certification Is Useful, Not a Victory Lap A battery box earning a safety certificate is not usually thrilling stuff, but the timing matters here. On Nov. 19, 2026, JDEnergy laid out its North American storage pitch at RE+ in Las Vegas while electricity demand is getting shoved higher by industrial buildout and AI data centers. Add more variable renewable generation to an...

Continue Reading
Vision Marine's Cash Cleanup Meets a Hard Reality Ahead

Updated Category News Views 162

A boat dealer slashing debt by $27.5 million deserves a nod, even when the rest of the ledger still makes your eyebrows climb. Vision Marine Technologies turned fiscal 2026 into a working-capital cleanup job: inventory came down hard, floor-plan financing nearly vanished, and operating cash flow finally turned positive. For NASDAQ:VMAR, that is real progress. It is not,...

Continue Reading
SAP Execution Can Steady Operations Beyond Spreadsheets

Updated Category News Views 87

Spreadsheets breed little kingdoms, and SAP is often left outside the gate. That is the operational mess Martin Rowan, managing partner at Reveal USA, Inc. in Naperville, is taking aim at in a Nov. 19, 2026 HelloNation feature. His central point is not terribly glamorous, but it is dead right: a company gets less stable when it uses SAP to explain yesterday's results...

Continue Reading
LKQ’s Europe ERP Mess Turns Into a Credibility Test

Updated Category News Views 98

A software rollout should not be able to punch a company in the teeth twice, yet LKQ shareholders have watched precisely that ugly movie in 2026. The October 23 disclosure was a real gut-check: an immediate CEO departure, a $16 million net loss, and renewed acknowledgement that the German enterprise-resource-planning rollout was disrupting Europe. Shares fell $5.05, or...

Continue Reading
Huawei's Financial AI Push Targets Scale, Not Demos

Updated Category News Views 23

Banking AI has reached the point where a clever chatbot barely moves the needle. Huawei's message at Singapore FinTech Festival 2026 was aimed squarely at that harder, more expensive problem: turning AI from a scattered pilot project into machinery a financial institution can operate, govern, repeat, and improve without handing over its crown jewels. Ownership Is the...

Continue Reading
CMS Audit Proposal Reopens Medicare Advantage Risk

Updated Category News Views 44

A regulator just tossed a rusted anchor into managed care's earnings model. CMS's proposed Comprehensive Regulations to Uncover Suspicious Healthcare rule, dubbed CRUSH and numbered CMS-6098-P, puts Medicare Advantage risk-adjustment audits back at center stage. The headline nobody can casually wave away: audit findings from sampled enrollees could be extrapolated across...

Continue Reading

Top 5 Most Recently Viewed Articles

Anticipating Autohome Inc.'s Financial Results for 2025

Updated Category News Views 150

Autohome Inc.'s Upcoming Financial Results Announcement Autohome Inc. (NYSE: ATHM) is on the verge of announcing its financial results for the second quarter and six months period ending June 30, 2025. As a leading platform for automobile consumers, Autohome continues to grow and adapt in an evolving market. Key Details on the Earnings Announcement The earnings report...

Continue Reading
NEXGEL Welcomes Industry Expert Kip Crecca to Advisory Team

Updated Category News Views 100

NEXGEL Expands Scientific Expertise with New Appointment NEXGEL, Inc. (NASDAQ: NXGL), renowned for its innovative medical and over-the-counter (OTC) products, has recently announced an exciting development. The company is thrilled to welcome Kip Crecca to its Scientific Advisory Board. This strategic addition showcases NEXGEL's dedication to enhancing its healthcare...

Continue Reading
Exciting Mixed-Use Development Takes Shape in Downtown Area

Updated Category News Views 318

Reimagining Urban Spaces: The Lewter District Development In an exciting development for urban living, RNGD and Emergent Properties are pioneering a remarkable mixed-use community known as the Lewter District. This project is set on a 1.5-acre plot, featuring 14 townhomes, a Class A office building, and an inviting farm-to-table restaurant, bar, and bakery. It's an...

Continue Reading
37th Parallel Expands DFW Footprint with Key Acquisition

Updated Category News Views 97

Picking Up Momentum in Dallas-Fort Worth Real Estate 37th Parallel Properties isn't messing around in the Dallas-Fort Worth market. They've snapped up Woodbridge Villas, a prime multifamily asset with 222 units tucked away in Sachse, Texas—a place with more charm than lawn gnomes in spring. This acquisition helps them expand their already hefty footprint in the South...

Continue Reading
Microchip Technology Announces Revenue Changes and Restructuring

Updated Category News Views 169

Microchip Technology's Updated Revenue Guidance for December Quarter Recently, Microchip Technology Incorporated, a prominent provider of smart embedded control solutions, has updated its revenue outlook for the upcoming quarter. The latest forecasts indicate a decline, with expectations set close to the lower end of their original guidance at $1.025 billion. This...

Continue Reading